Fornoni, Alessia
Merscher, Sandra
Kopp, Jeffrey B.
Article History
First Online: 27 May 2014
Competing interests
: S.M. and A.F. hold patent application numbers US13/879,892, PCT/US11/56272: 'Assays, methods and kits for predicting renal disease and personalized treatment strategies'; PCT/US2012/062594, 'Soluble urokinase receptor (suPAR) in diabetic kidney disease'; PCT/US13/36484, 'Method of using cyclodextrin'. A.F. is a consultant for Hoffman-La Roche and Mesoblast. J.B.K. Declares no competing interests.